Senior Scientist I, Clinical Biomarker Development

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. As a Senior Scientist I in Clinical Biomarker Development, you will join a team of outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Requirements

• PhD in a relevant scientific discipline
• 3+ years of relevant industry experience in clinical biomarkers, translational medicine, or related roles
• Experience supporting oncology clinical trials with biomarker components
• Familiarity with biomarker platforms such as genomic/molecular and proteomic assays
• Experience working with CROs and managing external vendors

Benefits

• Competitive cash compensation
• Robust equity awards
• Strong benefits
• Significant learning and development opportunities